The interplay of salt and aldosterone in determining ill-effects of aldosterone excess in the cardiovascular and renal system and stimulating salt appetite

Pimenta, Eduardo (2012). The interplay of salt and aldosterone in determining ill-effects of aldosterone excess in the cardiovascular and renal system and stimulating salt appetite PhD Thesis, School of Medicine, The University of Queensland.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
s42458030_phd_finalthesiscopy.pdf Thesis full text application/pdf 673.15KB 7
Author Pimenta, Eduardo
Thesis Title The interplay of salt and aldosterone in determining ill-effects of aldosterone excess in the cardiovascular and renal system and stimulating salt appetite
School, Centre or Institute School of Medicine
Institution The University of Queensland
Publication date 2012
Thesis type PhD Thesis
Supervisor Michael Stowasser
Total pages 136
Total black and white pages 136
Language eng
Subjects 110201 Cardiology (incl. Cardiovascular Diseases)
110306 Endocrinology
110312 Nephrology and Urology
Formatted abstract
           Aldosterone is a steroid hormone produced by the adrenal cortex and functions as the body’s principal physiological salt-regulating hormone. Aldosterone excess leads to excessive sodium and water retention and, consequentially, increased blood pressure (BP). Furthermore, aldosterone is associated with target-organ deterioration and increased cardiovascular morbidity independently of its effects on BP. High dietary salt intake is not only associated with development of hypertension, but also aggravates hypertension that is already present. Experimental studies have indicated that the combination of aldosterone excess and high-salt ingestion is necessary for induction of target-organ damage. This thesis comprises studies on the BP effects of dietary sodium restriction in patients with resistant hypertension, the effect of salt in determining urinary protein excretion and changes in the left ventricular (LV) structure and the relationship between aldosterone and salt appetite in patients with primary aldosteronism (PA).

           Salt and resistant hypertension
           Twelve subjects with resistant hypertension entered into a randomized crossover evaluation of low (50 mmol/24-hr X 7 days) and high (250 mmol/24-hr for X 7 days) sodium diets separated by a 2-week washout period. Office and 24-hr ambulatory BP was compared between dietary treatment periods. Mean urinary sodium (UNa) excretion was 46.1±26.8 (SD) versus 252.2±64.6 mmol/24-hr during low- versus high-salt intake. Low- compared to high-salt diet decreased office systolic and diastolic BP by 22.7 and 9.1 mm Hg respectively.

           Aldosterone, salt and urinary protein
           Twenty-four subjects with aldosterone producing adenoma (APA) underwent measurement of 24-hr urinary protein (Uprot) and UNa before and after unilateral adrenalectomy (ADX - follow-up 15.0±11.9 months). Following surgery, mean clinic systolic BP fell (150.4±18.2 vs 134.5±14.5mmHg, p=0.0008), despite a reduction in number of antihypertensive medications, and Uprot (211.2±101.6 vs 106.0±41.8mg per day, P<0.0001) decreased. There was a positive correlation between Uprot and UNa both before (r=0.5477, p=0.0056) and after (r=0.5097, p=0.0109) ADX. Changes in UNa independently predicted Uprot reduction (p=0.0189).

           Aldosterone, salt and LV hypertrophy
           A case-control study included 21 patients with confirmed PA and 21 control patients with essential hypertension matched for age, gender, duration of hypertension and 24-hr systolic and diastolic BP. Patients were evaluated by echocardiography and UNa excretion while consuming their usual diets. Patients with PA had significantly greater mean LV wall thicknesses and LV mass than control patients. UNa significantly positively correlated with, and was an independent predictor of, LV wall thicknesses and LV mass in patients with PA, but not in control patients.

           Aldosterone and salt appetite
           We compared pre- and post-operative UNa, collected on the last day (day 4) of fludrocortisone suppression testing (FST) in 93 patients with APA before and after ADX. In 35 of these patients, we also analysed UNa collected out of hospital. For the total cohort of 93 patients, day 4 UNa decreased from 328.2±78.5 mmol/day pre-operatively to 271.5±69.1 mmol/day (p<0.0001) postoperatively despite equal salt supplementation. Out of hospital UNa fell from 172.1±57.2 to 146.9±55.7 mmol/day (p=0.0183) after ADX. Interestingly, on subgroup analysis, UNa on day 4 FST fell significantly only in patients whose FST after ADX showed biochemical cure of PA (n=78), but not in those whose FST showed any remaining autonomous aldosterone production (n=15).

           These results indicate that excessive dietary sodium ingestion contributes importantly to resistance to antihypertensive treatment and that dietary salt modulates aldosterone-induced renal and cardiac damage in patients with PA. Our findings suggest that treatment strategies to substantially reduce dietary salt intake should be part of the overall treatment of resistant hypertension. Furthermore, in patients with PA, dietary salt restriction should provide additional target-organ protection to that afforded by reduction of aldosterone effects (by ADX or mineralocorticoid receptor blockade). This may be easier to achieve in treated patients as aldosterone reduction appears to reduce salt appetite.
Keyword Hypertension
Resistant hypertension
Primary aldosteronism
Left ventricular hypertrophy

Citation counts: Google Scholar Search Google Scholar
Created: Mon, 29 Oct 2012, 19:15:25 EST by Dr Eduardo Pimenta on behalf of Scholarly Communication and Digitisation Service